Biopharmaceutical Company Silo Pharma Launches Cryptocurrency Fund Management Strategy

Biopharmaceutical company Silo Pharma (NASDAQ: SILO) today announced the launch of its cryptocurrency fund management strategy and the appointment of crypto infrastructure expert Corwin Yu as the first member of its cryptocurrency advisory board. The strategy will focus on mainstream digital assets such as Bitcoin, Ethereum, and SOL. (Globenewswire)